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Background: Cardiac Troponin-T measured with a highly sensitive assay (hs-cTnT) has been suggested as a potential prognostic marker in acute 
heart failure, but studies in chronic heart failure populations are sparse. The aim of this study was to investigate the impact of hs-cTnT level on all-
cause mortality in an outpatient population with chronic systolic heart failure.
Methods: 438 patients with chronic systolic heart failure and a left ventricular ejection fraction (LVEF) ≤ 45% attending an outpatient heart failure 
clinic were enrolled. In addition to registration of clinical parameters, echocardiography, and routine biochemical measures including plasma NT-pro 
B-type Natriuretic Peptide (NT-proBNP), hs-cTNT was measured.
Results: Mean age in the population was 71 years, 29 % were females, 61 % had ischemic heart disease, and mean LVEF was 31 %. During a 
median of 4.4 years of follow-up 229 (52%) of patients died. In Cox-regression models containing age, gender, LVEF, serum creatinine, anaemia, body 
mass index, ischemic heart disease, New York Heart Association class and log-NT-proBNP as covariates, hs-cTnT was categorized as either quartiles 
(Q1: <10 ng/L, Q2: 10-18 ng/L, Q3: 18-32 ng/L, Q4: >32 ng/L) or dichotomized (normal versus abnormal) with the chosen cut-point being the 99th 
percentile of a healthy populations (Male: 18 ng/L, Female: 8 ng/L). 308 (70 %) of the population had hs-cTnT values above this 99th percentile 
limit. The adjusted hazard ratios for Q2-4 with Q1 used as reference were: Q2: 1.5 (95% CI 0.9-2.5, P=0.14), Q3: 1.6 (0.9-2.7, P=0.89), Q4: 2.8 
(1.6-4.8, P<0.001). The adjusted hazard ratio for abnormal vs. normal levels of hs-cTnT was 1.6 (1.0-2.6, P=0.04).
Conclusions: Highly sensitive cardiac Troponin T carries important prognostic information beyond clinical parameters and the established 
biomarker NT-proBNP in outpatients with chronic systolic heart failure of both ischemic and non-ischemic etiologies. Patients in the highest quartile 
of hs-cTnT had almost three times higher long-term mortality risk compared to patients in the lowest quartile. hs-cTnT might be of use in heart 
failure outpatient clinics by identifying subjects with very high risk of premature death.
